Citigroup initiated coverage on MoonLake Immunotherapeutics with a new price target
$MLTX
Biotechnology: Pharmaceutical Preparations
Health Care
Citigroup initiated coverage of MoonLake Immunotherapeutics with a rating of Buy and set a new price target of $72.00